December 18, 2024 - 00:36

MIAMI -- In a positive development for the Miami Marlins, left-handed pitcher Jesús Luzardo has announced that he is fully healthy and actively participating in his offseason training regimen. Speaking at a community event hosted by the Marlins Foundation, Luzardo expressed his enthusiasm about his recovery progress.
"I've been able to go through my normal offseason progression: throwing, running, starting to get off the mound," he shared, highlighting his commitment to returning to peak performance. Luzardo's recovery comes after a challenging season, and his current state is a welcome relief for both the player and the team's fans.
As Luzardo continues to build his strength and refine his skills, the Marlins are optimistic about his contributions in the upcoming season. His ability to throw without limitations is a promising sign, and the team is eager to see how he will impact their pitching rotation moving forward. Fans are hopeful that Luzardo's return to form will bolster the Marlins' chances in the competitive league.
July 21, 2026 - 17:42
Rare disease drugmakers try to avoid Trump price cutsPharmaceutical companies that specialize in treatments for rare diseases are scrambling to shield their products from possible price cuts under a potential second Trump administration. During his...
July 21, 2026 - 06:41
The rise of Zyn-like pouches for sleep, health, focus, teethThe success of Zyn nicotine pouches has sparked a wave of copycat products that promise to deliver everything from better sleep to sharper focus, all through a small pouch tucked inside the lip....
July 20, 2026 - 19:14
FDA says it’s still investigating Taylor Farms in cyclosporiasis outbreakThe U.S. Food and Drug Administration has clarified that a false-positive lab result does not alter the `overwhelming epidemiological data` pointing to Taylor Farms as the source of a...
July 20, 2026 - 11:31
Seven peptides are under review by an FDA panel this week. Here’s everything we knowA federal advisory committee is set to meet this week to evaluate seven peptide products, a move that could reshape how these compounds are made and prescribed in the United States. The panel,...